| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | -0.17 | 6e-07 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.17 | 0.0002 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0007 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0007 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0007 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.001 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.17 | 0.001 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.15 | 0.001 |